Align Technology analyst consensus in focus, shares trade on NASDAQ
28.06.2026 - 13:15:08 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 13:14.
Align Technology (US0162551016) enters the new trading week with a distinct analyst consensus profile on the NASDAQ. Data from several platforms show a cluster of price targets around the high-100-dollar range and a mixed rating distribution between Buy and Hold, setting a cautious tone for retail investors following the stock.MarketBeat analyst overview for Align Technology
What analysts currently expect
Recent consensus data compiled by MarketBeat place the average 12-month price target for Align Technology shares at roughly 178 to 210 dollars, with individual targets spanning a wider band as strategists update their models after the latest quarterly report.PandaForecast summary of ALGN targets and forecasts Several U.S. brokers highlight the company’s exposure to elective dental spending and consumer confidence, which often leads to more conservative valuation multiples than those applied to high-growth software names in the S&P 500.
The rating mix shows a majority of firms in the Buy and Outperform camp, yet with a notable minority preferring Neutral or Hold due to sensitivity to macroeconomic conditions and foreign exchange effects on international sales.MarketBeat breakdown of ratings and recommendations This split is visible in the dispersion of price targets, where some houses still see upside towards the low-200-dollar range, while more cautious analysts anchor their targets closer to present trading levels.
How the shares most recently traded
On 26 June 2026 Align Technology shares closed at 178.43 dollars on the NASDAQ, after an intraday range between about 174 and 179 dollars and a trading volume reported around 1.67 million shares, indicating active participation but not exceptional volatility that day.Pandaforecast trading data for ALGN on 26 June 2026 Extended trading later that evening showed quotes drifting slightly lower, with figures around the mid-170-dollar area, consistent with the stock’s recent pattern of modest day-to-day moves.
Short-term model-based projections referenced on PandaForecast point to near-term target levels in the high-170 to around 181-dollar range for early July, reflecting expectations of relatively stable trading without sharp deviations ahead of the next earnings event.Pandaforecast near-term price projection for ALGN While such quantitative forecasts are not investment advice, they offer a numerical frame that many retail investors use alongside broker research to gauge possible trading corridors.
All news and analysis on the Align Technology shares
Further background, ad hoc releases and previous articles on Align Technology shares are collected in the topic section for the US0162551016 listing.
The product behind the stock
Align Technology generates most of its revenue with its Invisalign clear aligner system, a series of custom-made transparent trays that gradually straighten teeth as an alternative to traditional metal braces.Align Technology product overview for Invisalign The company supports this flagship product with its iTero intraoral scanners and associated software platforms, which enable digital impressions and treatment planning for orthodontists and dentists worldwide.
Where the shares trade today
Align Technology shares (US0162551016) last traded on the NASDAQ on 2026-06-26 at 178.43 dollars during regular hours, with market data providers reporting a market capitalization in the mid-teen billion-dollar range based on that closing price.MarketWatch quote and market cap data for ALGN
Align Technology at a glance
- Company: Align Technology, Inc.
- ISIN: US0162551016
- WKN: 593373
- Ticker: ALGN
- Trading venue: NASDAQ
- Price (as of 2026-06-26, 16:00): 178.43 USD
- Market cap: approximately 14-15 billion USD (as of 2026-06-26)
- Sector / industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data are based on sources believed to be reliable but cannot be guaranteed; investors should conduct their own research or consult a financial advisor before making investment decisions.
